Information Provided By:
Fly News Breaks for May 3, 2017
EVHC
May 3, 2017 | 08:28 EDT
Canaccord analyst Richard Close lowered his price target on Envision Healthcare to $68 from $86 but tells investors to remain patient through the post-merger strategic review and softer volume environment as the cross-sell of physician services is successful. Close maintained his Buy rating on Envision Healthcare shares.
News For EVHC From the Last 2 Days
There are no results for your query EVHC